18F-RO6958948
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 18F-RO6958948, covering 2017-11-01 to 2025-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population [NA]